top of page

The intelligence layer for pharmaceutical compliance. A New Way to See Pharma Regulations

Pharmaceutical development doesn’t slow down—but compliance often does. From INDs and NDAs to global submissions across EMA, PMDA, and beyond, every delay carries real costs: lost revenue, delayed therapies for patients, and mounting regulatory risk.
Pharma Lens™ was built to change that. It’s Lexim AI’s dedicated intelligence module for the pharmaceutical industry, designed to cut through regulatory complexity with speed, precision, and clarity. With Pharma Lens™, your team sees exactly what matters—faster than ever before.

Pharma Lens™

What Pharma Lens™ Delivers

Pharma Lens™ combines domain-trained AI with regulatory expertise to give pharmaceutical organizations a distinct advantage:

  • Clarity at Scale
    No more scanning endless guidance PDFs. Pharma Lens™ interprets regulatory language, highlights relevant sections, and delivers the insight in plain, actionable terms.

  • Submission Confidence
    From IND to NDA, dossiers are assembled and validated with AI precision—reducing manual effort, minimizing rework, and accelerating approval timelines.

  • Always Current, Always Proactive
    Global regulatory changes—whether EMA updates on labeling or FDA guidance on safety reporting—are monitored continuously, so your teams are never caught off guard.

  • Cross-Document Intelligence
    Connect data points across trial protocols, study reports, and regulatory filings. Pharma Lens™ helps ensure nothing is overlooked, and everything is consistent.



Why It Matters

Pharma is a high-stakes environment where a single error can cost millions and a single delay can cost lives. Traditional search tools and manual reviews simply can’t keep pace.

Pharma Lens™ transforms regulatory information into a strategic advantage: accelerating submissions, strengthening quality, and giving executives real-time confidence that compliance is never a bottleneck.



Designed for Every Team

  • Regulatory Affairs: Get answers, validate dossiers, and prepare submissions faster.

  • Quality: Ensure SOPs and QMS systems reflect evolving global standards.

  • Clinical & Product Teams: Integrate compliance checkpoints early in development to avoid late-stage surprises.

  • Leadership: Gain visibility into regulatory readiness across global programs.



The Outcomes with Pharma Lens™

Organizations using Pharma Lens™ report:

  • Faster market entry for new drugs and therapies.

  • Reduced regulatory risk, with fewer errors and missed updates.

  • Greater alignment between teams working across development, quality, and compliance.

  • Sustained inspection readiness, globally.



Part of the Lexim AI Suite

Pharma Lens™ works seamlessly with Lexim AI’s full suite of automation and intelligence tools—including Regulatory Information Agents, Submission Agents, and Workflow Automation Agents—to create an end-to-end compliance ecosystem for the pharmaceutical industry.

What Our Clients Say

image.png

Tatyana G., Vice-president of Regulatory Affairs

"Lexim helped my medical-device company gain a deep understanding of AI and its applications to Regulatory Affairs."

bottom of page